DURECT (DRRX) Reports Q4 Loss of $0.24
More News related to DRRX
- DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
- DURECT Corporation (DRRX) Reports Smaller-Than-Expected Loss on Higher Revenues
- DURECT Corporation Announces Third Quarter 2009 Financial Results
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
More News related to Earnings
- Apple (AAPL) Investors Show Nervousness On Speculation T-Mobile Could Be Next iPhone Carrier
- Positives Seen On BioCryst (BCRX) After Peramivir Granted Priority Review In Japan
- Baird Comments on Onyx Pharmaceuticals (ONXX) On China NDRL Update
- Goldman Sachs Lifts Price Target on WellCare (WCG) to $40
- Applied Materials (AMAT) Sees Upside and Option Investors Place Potentially Bullish Bets
DURECT Corporation (Nasdaq: DRRX) reports Q4 loss of $0.24, versus the analyst estimate of ($0.11). Revenue for the quarter was $6.6 million, versus the consensus of $6.72 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
